Goldman Sachs Maintains Sell on Elanco Animal Health, Raises Price Target to $9.5
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Nathan Rich maintains a 'Sell' rating on Elanco Animal Health (NYSE:ELAN) and raises the price target from $8.5 to $9.5.
August 09, 2023 | 3:44 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Goldman Sachs maintains a 'Sell' rating on Elanco Animal Health and raises the price target. This could potentially lead to a negative sentiment among investors.
The 'Sell' rating maintained by Goldman Sachs indicates a negative outlook for Elanco Animal Health. Although the price target has been raised, it may not be enough to offset the negative sentiment caused by the 'Sell' rating. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100